Skip to Main Content

Paper Details

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phaseâ¿¿II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).
Ther Adv Med Oncol
4
2020
Author NameAffiliation
Susana BanerjeeThe Royal Marsden NHS Foundation Trust
Nina TunariuThe Royal Marsden Hospital NHS Foundation Trust
Gerhardt AttardUCL Cancer Institute, University College London
  • 1 - 3

Datasets

Release 1.2